Cyclo Therapeuticsincis A Clinical Stage Biotechnology Company Focused On Developing Innovative Medicines For Patients With Challenging Diseasesthe Company Specializes In The Use Of Cyclodextrins In Drug Developmentaiming To Create Therapeutic Solutions That Enhance The Quality Of Life For Individuals Affected By Conditions Such As Niemann Pick Disease Type C And Alzheimerae S Disease Their Lead Producttrappsolacycloa Cis A Proprietary Formulation Of Hydroxypropyl Beta Cyclodextrinit Is Designed To Aid In The Transport Of Cholesterol Out Of Cellular Lysosomesaddressing The Issues Caused By The Defective Npc1 Proteintrappsolacycloa C Is Currently Undergoing Clinical Trialsincluding A Phase 3 Study To Assess Its Efficacy In Treating Niemann Pick Disease Type C1 In Both Pediatric And Adult Patientscyclo Therapeutics Is Committed To Advancing Its Research And Providing Meaningful Therapeutic Options For Those In Need
